salicylic acid 0.02 MG/MG Topical Gel [Stri-Dex Clear Gel]
RxNorm concept 212812, branded drug (sbd). Prescribable name: STRIDEX Clear Gel 2 % Topical Gel.
- RxCUI
- 212812
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/212812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Stri-Dex Clear Gel 0.02 MG/MG Topical Gel; Stri-Dex Clear Gel 2 % Topical Gel
Related concepts
- salicylic acid 0.02 MG/MG (SCDC, consists of)
- salicylic acid 0.02 MG/MG [Stri-Dex Clear Gel] (SBDC, consists of)
- Topical Gel (DF, has dose form)
- Stri-Dex Clear Gel (BN, has ingredient)
- salicylic acid 0.02 MG/MG Topical Gel (SCD, tradename of)
Linked data
NDCs
- 41388006633
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 212812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/212812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 212812. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.